Pfizer and Protalix BioTherapeutics announced that the Food and Drug Administration (FDA) has approved Elelyso (taliglucerase alfa) for injection for pediatric patients.
Fresenius Kabi announced the Food and Drug Administration has approved Kabiven and Perikabiven in a 3-chamber bag.
Genzyme announced that the Food and Drug Administration (FDA) has approved Cerdelga (eliglustat) capsules for the treatment of certain adult Gaucher disease type 1 patients.
Antibiotic exposure during a critical window of early development alters the gut microbes and permanently reprograms the body's metabolism, which may increase one's susceptibility to obesity.
The Food and Drug Administration (FDA) has issued an alert regarding an ingredient commonly found in gluten-free products that may cause anaphylaxis in patients with a legume allergy.
The Food and Drug Administration (FDA) is warning consumers not to purchase or use products sold online claiming to prevent or treat the Ebola virus.
B. Braun Medical Inc. announced that the FDA has approved Nutrilipid 20% (IV fat emulsion) for parenteral nutrition therapy in adult and pediatric patients.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Arize and Herbal Vigor Quick Fix, products marketed for sexual enhancement.
Regeneca announced a voluntary nationwide recall of its RegenESlim appetite control dietary supplement.
The FDA published a new regulation to provide a uniform definition of the term "gluten-free" for voluntary food labeling to help those who have celiac disease.
The FDA announced the approval of Lumizyme (alglucosidase alfa; Genzyme) for the treatment of all patients with infantile-onset Pompe disease.
A new Similac breastfeeding supplement is specially designed to enhance the levels of DHA, lutein, and vitamin E in breastmilk.
Reports of lifetime use of synthetic human growth hormone (hGH) without a prescription has more than doubled since 2012 among teens, while alcohol consumption has significantly decreased and marijuana use has remained steady, states a new study from the Partnership for Drug-Free Kids.
The FDA is warning consumers not to purchase or use O.M.G., a product marketed for sexual enhancement.
The FedEx Corporation has been indicted with charges relating to conspiracies with two separate but related online pharmacy organizations to distribute misbranded prescription drugs and controlled substances to U.S. consumers without requiring a valid prescription.
Libertas Pharma announced the launch of Multivitamins with A, B, D, E and K plus Zinc in three different formulations for patients with malabsorptive conditions, including cystic fibrosis.
Baxter announced a voluntary recall of one lot of highly concentrated Potassium Chloride Injection 20mEq/50mL in a ViaFlex Container and three lots of 0.9% Sodium Chloride Injection due to particulate matter, found in the solutions.
The FDA is warning consumers to not buy or use 6 supplements that are promoted for weight loss.
Adults with extreme obesity have increased risks of dying at a young age from cancer and other conditions, including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of a pooled analysis.
The FDA is alerting healthcare professionals not to use injectable vitamin products distributed by Medical Supply Liquidators LLC in Clive, IA, with "Sunshine Labs" on the label.
Doctor's Best announced a voluntary nationwide recall of over 7,000 bottles of Red Yeast Rice dietary supplements 600mg capsules used to lower cholesterol.
Vertex announced results from two Phase 3 studies of lumacaftor in combination with ivacaftor in patients with cystic fibrosis (CF) who have two copies of F508del mutation in the CFTR gene.
The owner and CEO of Balanced Health Products (BHP) has been sentenced by a U.S. magistrate judge in Manhattan federal court to a $60,000 penalty for distributing dietary supplements that contained a prescription drug.
Consider the evidence base and recommend probiotics on a case-by-case basis.
Two studies presented at 2014 American Diabetes Association Scientific Sessions found that adults living in areas with greater walkability had a lower risk of developing diabetes over a 10-year period and that walkable neighborhoods have the lowest incidence of obesity, overweight, and diabetes.
The FDA is advising consumers not to buy or use the product Toxin Discharged Tea, a product promoted and sold for weight loss due to an undeclared ingredient.
The FDA is advising consumers to not purchase or use Gold Vigra, a product marketed and sold for sexual enhancement.
Two studies presented at the 2014 American Diabetes Association Scientific Sessions highlight the relationship between children's consumption of sugary beverages and neurological reactions, as well as changes to fat cell composition in obese children.
LipoScience, Inc. announced data on their nuclear magnetic resonance (NMR)-based diagnostic test to identify normal-weight individuals at high risk of developing type 2 diabetes.
New clinical guidelines on the diagnosis and management of idiosyncratic drug-induced liver injury (DILI) have been issued by the American College of Gastroenterology, which include a focus on herbal and dietary supplements
A study presented at the 2014 American Diabetes Association Scientific Session reported that improving the overall quality of one's diet helps to prevent type 2 diabetes apart from other lifestyle changes.
At the 2014 American Diabetes Association Scientific Sessions, GI Dynamics presented study findings that demonstrated the acute effects of EndoBarrier Therapy on glycemic control as well as data that help explain its potential mechanism of action.
Obese patients with rheumatoid arthritis (RA) have higher disease activity scores (DAS) than non-obese patients, regardless of their disease stage, scientists presented at EULAR 2014.
Strativa announced that the FDA has approved Nascobal (cyanocobalamin) Nasal Spray for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement.
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) issued draft updated advice regarding the consumption of fish by pregnant and breastfeeding women and young children.
The FDA is advising consumers not to buy the product B-Perfect, promoted and sold for weight loss, after a laboratory analysis discovered undeclared sibutramine and phenolphthalein.
The FDA is warning consumers that several products promoted and sold for sexual enhancement have been found to contain undeclared ingredients and should not be purchased or used.
TherapeuticsMD announced the launch of newly reformulated vitaMedMD RediChew Rx, a branded prescription prenatal vitamin, and Prena1 Chew, a generic prescription prenatal vitamin.
Essentialis announced that the FDA has granted orphan drug designation to diazoxide choline, the active ingredient in DCCR for the treatment of Prader-Willi syndrome.
The FDA is advising consumers to not buy or use Asset Bold, a product sold for weight loss.
The FDA is advising consumers not to purchase or use MV5 Days, a product marketed for sexual enhancement.
Novo Nordisk announced results from its Phase 3a trial evaluating liraglutide 3mg, an investigational once-daily glucagon-like peptide-1 (GLP-1) analogue for weight management. Liraglutide regulates appetite and food intake by decreasing hunger and increasing feelings of fullness and satiety after eating.
The FDA is advising consumers to not purchase or use Asset Bee Pollen, a product promoted and sold for weight loss on various websites and retail stores.
Eating more fruits and vegetables could reduce the risk of stroke worldwide, with stroke risk decreasing as consumption increases.
GI Dynamics and GlaxoSmithKline announced results from a study on EndoBarrier and increased postoperative levels of bile acids (BAs) in patients with severe obesity, with and without type 2 diabetes.
The FDA is advising consumers not to purchase or use Slim Trim U and Natural Body Solution, two products marketed and sold for weight loss.
According to research presented at Digestive Disease Week, bariatric surgery may results in significant improvement in nonalcoholic fatty liver disease (NAFLD).
Bacai is issuing a voluntary recall at the retail and consumer level of one lot of LiteFit USA capsules, an herbal dietary supplement.
In response to the critical shortage of 0.9% Sodium Chloride (normal saline) injection, Baxter announced it will temporarily distribute in the U.S. normal saline produced in its Spain manufacturing facility.
Flawless Beauty and Skin has announced that it is voluntarily recalling 11 lots of products due to the inclusion of drugs not approved in the US.
Nano Well-Being Health is issuing a voluntary recall of two lots of Super Arthgold 500mg capsules, a dietary supplement for joint pain and arthritis.
Nature's Universe announced a voluntary recall of all lots of old Thinogenics product due to the presence of an undisclosed ingredient, to the user level.
The FDA is advising consumers to not buy or use Infinity capsules or Lite Fit USA softgels, products that are marketed and sold for weight loss.
The FDA is warning consumers to avoid using or purchasing the herbal weight loss product New You after a laboratory analysis discovered undeclared sibutramine and phenolphthalein.
Changes to the colon that may lead to colorectal cancer appear to be caused by obesity, rather than diet, in mice.
New research suggests that women who eat a diet high in fresh fruits and vegetables as young adults have a significantly reduced risk of artery plaque build-up in the future.
GlaxoSmithKline announced a voluntary recall of all Alli (orlistat) weight loss products due to the belief that some packages were tampered and may contain product that is not authentic Alli.
Pure Edge Nutrition announced a voluntary recall of one lot of Bella Vi Insane Bee Pollen Capsules, Bella Vi BTrim Ultimate Boost, Bella Vi BTrim Max, Bella Vi Extreme Accelerator, Bella Vi Insane Amp'd, and two lots of Bella Vi Amp'd Up.
New Life announced a voluntary nationwide recall of Super Fat Burner capsules, Maxi Gold capsules, and Esmeralda softgels after an FDA analysis revealed the products contain undeclared pharmaceutical ingredients: sibutramine, phenolphthalein or a combination of both.
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have released an evidence-based, multi-dimensional, comprehensive framework for fighting obesity.
Among white adults, larger waist is associated with increased mortality at all levels of body mass index.
Consumption of fried foods may influence the genetic association with adiposity.
Terra-Medica is voluntarily recalling 56 lots of Pleo Homeopathic products due to the possible presence of penicillin or penicillin derivatives.
The FDA is advising consumers to not buy or use Vitaccino Coffee, a product promoted for weight loss.
TherapeuticsMD, Inc. (parent company of vitaMedMD, LLC) announced the launch of vitaPearl, the latest addition to the vitaMedMD prenatal multivitamin line.
Feeding and activity behaviors thought to relate to later obesity differ by race and ethnicity.
Personality measurements can be useful tools in predicting which young adult patients will have poor health in middle age.
For girls, obesity at age 11 years has a negative effect on academic attainmen, with no strong evidence for potential mediating effects of depressive symptoms, IQ, and age of menarche.
Among older men, higher intake of protein, particularly animal protein, is associated with lower risk of decline in higher-level functional capacity.
Edison Pharmaceuticals announced that the FDA has granted Fast Track designation to EPI-743, a study drug for the treatment of Friedreich's ataxia.
Shire announced the a voluntary recall of one batch of Vpriv (velaglucerase alfa) due to the presence of visible stainless steel and barium sulfate in a number of vials.
Higher concentrations of serum 25-hydroxyvitamin D (25[OH]D) are associated with lower mortality from breast cancer.
Learning how to evaluate complementary and alternative medical (CAM) therapies can empower healthcare providers to deliver better integrative care and increase patient satisfaction with the U.S. healthcare system.
For adults of European origin, increased body mass index (BMI) is associated with methylation at three sites in intron 1 of HIF3A.
Oral glucosamine supplementation is not associated with a decrease in knee cartilage deterioration among individuals with chronic knee pain.
According to a recent study, health providers do not routinely provide health education to patients with chronic disease.
Body fatness, marked by body mass index, is likely associated with an increased risk of ovarian cancer.
Despite launch of salt reduction campaign, dietary salt intake remains high among South London youth.
For obese adolescents, sleep duration independently predicts cardiometabolic risk.
Following a "prudent" or "traditional" diet is associated with a reduced risk of preterm delivery.
Higher body mass index (BMI) is associated with increased cost of care and longer hospital stays for patients who present to the emergency department with chest pain and dyspnea.
The WHO announced the opening of a public consultation regarding their draft guideline on sugar intake.
For children and adolescents, having a television in the bedroom is associated with increased body mass index (BMI), while active video gaming can increase physical activity and weight loss.
High intake of dietary advanced glycation end products (AGEs), which have been linked to Alzheimer's disease and metabolic syndrome, are associated with cognitive and motor deficits and insulin resistance in mice and humans.
Exposure to perfluorinated and polyfluorinated chemicals is associated with increased insulin and triglyceride concentrations in overweight children.
There is a significant association between low vitamin D status and markers of inflammation in elderly adults.
Higher food prices not associated with food insecurity
The FDA has proposed a new format for the Nutrition Facts label for packaged foods to highlight changes in nutrition science and food packaging.
The prevalence of obesity among youth or adults in the United States did not change significantly between 2003-2004 and 2011-2012.
Use of supplementation with in-hospital formula shortens the duration of breastfeeding among first-time mothers who intend to breastfeed exclusively
Adjuvant high-dose vitamin D3 is beneficial for patients with chronic urticaria.
The FDA has approved Myalept (metreleptin; Bristol-Myers Squibb) for injection as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy.
People with defective pulmonary capillary filtration are at higher risk of having an ischemic stroke if they have low iron levels.
The USPSTF has found that insufficient evidence to evaluate the benefits and harms of multivitamins and most single- or paired-nutrient supplements for the prevention of cardiovascular disease and cancer.
Patients who discuss weight loss with their physicians but do not feel judged may be more likely to attempt and succeed in losing weight.
The FDA has approved a sNDA for Kalydeco (ivacaftor; Vertex) for use in patients with cystic fibrosis (CF) ages >6 years old who have 1 of 8 additional mutations in the CF transmembrane conductance regulator (CFTR) gene.
The PAR protocol has been validated as a new method for calculating the estimated energy requirements (EERs) and daily average physical activity ratio (APAR) at the population level.
Early fetal retinoic acid (RA) deficiency is associated with altered airway smooth muscle phenotype, with RA restricting airway smooth muscle differentiation.
Tamoxifen that has been identified in samples of the dietary supplement Esto Suppress.
A new non-surgical medical device is currently undergoing clinical trials in the U.S. for the treatment of type 2 diabetes in patients who are also trying to lose weight.